These findings highlight the pivotal roles of Hsp90α and HMGB1 in UUO‐ and FA‐related renal fibrosis and suggest the potential therapeutic value of LM49 in CKD treatment in the clinical. The gene discussed is HSP90AA1; the disease is chronic kidney disease.